Terms: = Pancreatic cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
2409 results:
1. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
[TBL] [Abstract] [Full Text] [Related]
2. Same People, Different Results: Categorizing cancer Registry Cases Across the Rural-Urban Continuum.
Schiefelbein AM; Krebsbach JK; Taylor AK; Haimson AK; Varley PR; Skala MC; Eason JM; LoConte NK
WMJ; 2024 May; 123(2):78-87. PubMed ID: 38718234
[TBL] [Abstract] [Full Text] [Related]
3. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma.
Tang H; Miao X; Yu C; Chai C; Su Y; Li L; Yi J; Ye Z; Miao L; Wang Z; Zhang H; Xu H; Zhou W
Sci Rep; 2024 Apr; 14(1):9259. PubMed ID: 38649719
[TBL] [Abstract] [Full Text] [Related]
4. Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray,
Hefny SM; El-Moselhy TF; El-Din N; Giovannuzzi S; Bin Traiki T; Vaali-Mohammed MA; El-Dessouki AM; Yamaguchi K; Sugiura M; Shaldam MA; Supuran CT; Abdulla MH; Eldehna WM; Tawfik HO
J Med Chem; 2024 May; 67(9):7406-7430. PubMed ID: 38642371
[TBL] [Abstract] [Full Text] [Related]
5. Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis.
Wehrle CJ; Chang JH; Gross AR; Woo K; Naples R; Stackhouse KA; Dahdaleh F; Augustin T; Joyce D; Simon R; Walsh RM; Naffouje SA
Surg Endosc; 2024 May; 38(5):2602-2610. PubMed ID: 38498210
[TBL] [Abstract] [Full Text] [Related]
6. Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line.
Szász Z; Enyedi KN; Takács A; Fekete N; Mező G; Kőhidai L; Lajkó E
Biomed Pharmacother; 2024 Apr; 173():116293. PubMed ID: 38430628
[TBL] [Abstract] [Full Text] [Related]
7. Whole-transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
Hashimoto T; Nakamura Y; Mishima S; Nakayama I; Kotani D; Kawazoe A; Kuboki Y; Bando H; Kojima T; Iida N; Shibuki T; Imai M; Fujisawa T; Nagamine M; Sakamoto N; Kuwata T; Yoshino T; Shitara K
Cancer Sci; 2024 May; 115(5):1622-1633. PubMed ID: 38429886
[TBL] [Abstract] [Full Text] [Related]
8. A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
Enzler T; Nguyen A; Misleh J; Cline VJ; Johns M; Shumway N; Paulson S; Siegel R; Larson T; Messersmith W; Richards D; Chaves J; Pierce E; Zalupski M; Sahai V; Orr D; Ruste SA; Haun A; Kawabe T
Eur J Cancer; 2024 Apr; 201():113950. PubMed ID: 38422585
[TBL] [Abstract] [Full Text] [Related]
9. Liquid Biopsy for pancreatic cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
Takahashi K; Inuzuka T; Shimizu Y; Sawamoto K; Taniue K; Ono Y; Asai F; Koyama K; Sato H; Kawabata H; Iwamoto H; Yamakita K; Kitano Y; Teramoto T; Fujiya M; Fujii S; Mizukami Y; Okumura T
Pancreas; 2024 May; 53(5):e395-e404. PubMed ID: 38416857
[TBL] [Abstract] [Full Text] [Related]
10. Irreversible Electroporation-Induced Inflammation Facilitates Neutrophil-Mediated Drug Delivery to Enhance pancreatic cancer Therapy.
Huang T; Wen X; Liang Y; Liu X; Zhao J; Long X
Mol Pharm; 2024 Apr; 21(4):1998-2011. PubMed ID: 38412284
[TBL] [Abstract] [Full Text] [Related]
11. Clinical impacts of positive intraepithelial neoplasia at pancreatic transection margin in pancreatic cancer surgery.
Takada S; Makino I; Katano K; Sugita H; Tokoro T; Gabata R; Okazaki M; Nakanuma S; Ikeda H; Toyama T; Yagi S
Pancreatology; 2024 May; 24(3):493-496. PubMed ID: 38378436
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial.
Qiu X; Lu C; Sha H; Zhu Y; Kong W; Tong F; Wang Q; Meng F; Liu B; Du J
Front Immunol; 2024; 15():1210859. PubMed ID: 38361920
[TBL] [Abstract] [Full Text] [Related]
13. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
[TBL] [Abstract] [Full Text] [Related]
14. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
Yang X; Lian B; Zhang N; Long J; Li Y; Xue J; Chen X; Wang Y; Wang Y; Xun Z; Piao M; Zhu C; Wang S; Sun H; Song Z; Lu L; Dong X; Wang A; Liu W; Pan J; Hou X; Guan M; Huo L; Shi J; Zhang H; Zhou J; Lu Z; Mao Y; Sang X; Wu L; Yang X; Wang K; Zhao H
BMC Med; 2024 Jan; 22(1):42. PubMed ID: 38281914
[TBL] [Abstract] [Full Text] [Related]
15. Implementation and outcome of minimally invasive pancreatoduodenectomy in Europe: a registry-based retrospective study - a critical appraisal of the first 3 years of the E-MIPS registry.
Emmen AMLH; de Graaf N; Khatkov IE; Busch OR; Dokmak S; Boggi U; Groot Koerkamp B; Ferrari G; Molenaar IQ; Saint-Marc O; Ramera M; Lips DJ; Mieog JSD; Luyer MDP; Keck T; D'Hondt M; Souche FR; Edwin B; Hackert T; Liem MSL; Iben-Khayat A; van Santvoort HC; Mazzola M; de Wilde RF; Kauffmann EF; Aussilhou B; Festen S; Izrailov R; Tyutyunnik P; Besselink MG; Abu Hilal M;
Int J Surg; 2024 Apr; 110(4):2226-2233. PubMed ID: 38265434
[TBL] [Abstract] [Full Text] [Related]
16. Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression.
Abu-Humaidan AH; Ismail MA; Ahmad FM; Al Shboul S; Barham R; Tadros JS; Alhesa A; El-Sadoni M; Alotaibi MR; Ababneh NA; Saleh T
Immunol Cell Biol; 2024 Apr; 102(4):240-255. PubMed ID: 38265162
[TBL] [Abstract] [Full Text] [Related]
17. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
Labori KJ; Bratlie SO; Andersson B; Angelsen JH; Biörserud C; Björnsson B; Bringeland EA; Elander N; Garresori H; Grønbech JE; Haux J; Hemmingsson O; Liljefors MG; Myklebust TÅ; Nymo LS; Peltola K; Pfeiffer P; Sallinen V; Sandström P; Sparrelid E; Stenvold H; Søreide K; Tingstedt B; Verbeke C; Öhlund D; Klint L; Dueland S; Lassen K;
Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):205-217. PubMed ID: 38237621
[TBL] [Abstract] [Full Text] [Related]
18. Intracellularly delivered human lactoferrin functions as an activator of Na
Kurimoto D; Hue Anh TD; Kasama R; Sato A
Biochem Biophys Res Commun; 2024 Feb; 695():149480. PubMed ID: 38215552
[TBL] [Abstract] [Full Text] [Related]
19. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
Urganci N; Kepil N; Ergun S; Bakkaloglu OK
J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
[TBL] [Abstract] [Full Text] [Related]
20. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
[Next]
